BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29393362)

  • 1. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway.
    Su CC
    Int J Mol Med; 2018 Apr; 41(4):2389-2396. PubMed ID: 29393362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
    Su CC
    Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
    Su CC
    Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.
    Su CC
    Oncol Rep; 2018 Nov; 40(5):3102-3111. PubMed ID: 30226540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo.
    Su CC; Chiu TL
    Oncol Rep; 2016 Aug; 36(2):1173-9. PubMed ID: 27277844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κB-p65 and cyclooxygenase-2.
    Su CC
    Mol Med Rep; 2016 Feb; 13(2):1263-8. PubMed ID: 26648518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
    Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
    Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
    Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
    Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.
    Zu Y; Wang J; Ping W; Sun W
    Mol Med Rep; 2018 Feb; 17(2):2384-2392. PubMed ID: 29207086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Tanshinone IIA on apoptosis of human esophageal carcinoma Eca-109 cells and its molecular mechanism.
    Zhang Y; Li S; He H; Han Q; Wang B; Zhu Y
    Thorac Cancer; 2017 Jul; 8(4):296-303. PubMed ID: 28407361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo.
    Su CC; Lin YH
    Int J Mol Med; 2008 Dec; 22(6):847-51. PubMed ID: 19020785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression.
    Cheng CY; Su CC
    Int J Mol Med; 2010 Sep; 26(3):379-85. PubMed ID: 20664954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
    Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo.
    Chen J; Shi DY; Liu SL; Zhong L
    Oncol Rep; 2012 Feb; 27(2):523-8. PubMed ID: 22038415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
    Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H
    Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
    Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
    J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
    Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
    Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
    Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
    Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.